
I have seen patients in my clinic who believed the X39 marketing: that a small sticker, for about the cost of a monthly phone bill, would activate their stem cells. I understand why. Next to a medical procedure, it sounds like a bargain. That is the pitch behind LifeWave's X39 patch, one of the fastest-growing products in network marketing.
Before you buy it, or sign up to sell it, you should know three things: what LifeWave and its sellers have claimed, what the science shows, and what the Federal Trade Commission found when it looked at how the patch is sold.
A disclosure first. I perform BMAC (stem cells) and PRP procedures, so I have a financial interest in this subject. That is exactly why every fact below links to its source. Check my work.
What the patch claims to do
X39 is an adhesive patch about the size of a quarter. According to LifeWave, nothing in it enters your skin. The company has said the patch reflects your body's own infrared light back into the skin. That supposedly raises a copper peptide called GHK-Cu, which in turn "activates" your stem cells. Sellers hang a long list of benefits on that chain: less pain, better sleep, faster healing, more energy, younger skin.
What LifeWave and its sellers have said
Here is how the claims have been worded over the years, in LifeWave's own press releases and website and in its sellers' materials.
- 2016, LifeWave press release. CEO David Schmidt said the patch "starts to reduce the inflammation immediately." Source
- 2021, LifeWave press release. The company said its patches use "nano-scale crystals and infrared light to enhance stem cell activity." Source
- 2023, LifeWave website. "Activate your stem cells!" This is as quoted by UC Davis stem cell biologist Paul Knoepfler in his February 2023 review. Source
- About 2023, seller handout. It states that GHK-Cu is "clinically proven to activate your body's own stem cells" and that X39 is the result of more than 80 clinical studies. Source
- 2025, seller post flagged by an industry watchdog. "Benefits can be immediate!" The watchdog reported that LifeWave did not try to back it up and had the post removed instead. Source
- 2026, LifeWave's own X39 page. It says "Activate the Power of Your Stem Cells," but a footnote credits that to CyanthOx in Cellergize Morning, a supplement sold with the patch. Source
- 2026, LifeWave's Cellular Performance System page (the patch-plus-supplement bundle, linked from the X39 page). It says X39 "uses phototherapy to elevate the peptide GHK-Cu." I captured both pages on November 16, 2026.
Notice the drift. LifeWave's X39 page now leads with energy, strength and stamina. Its stem cell line points, by footnote, to a supplement, and the page carries the standard notice that its statements have not been evaluated by the FDA. But the GHK-Cu claim is still there, and that is the one link in the chain anyone has tested. The patch is also still sold as the stem cell patch. One seller lists a 90-day supply as "X39 Stem Cell Activation Patches" for $399 (source). I can't tell you why LifeWave changed its wording. I can tell you the claim patients hear is the one in the sellers' materials.
Each link in that chain is a claim that can be tested. So I looked for the tests.
Three problems with the stem cell story
1. A patch that gives off no light is not light therapy
Real light therapy, called photobiomodulation, uses a device that produces light, usually a laser or LED. It works at a set wavelength, a set power and a set dose, and the studies report all three. A sticker produces no light of its own. The heat your body gives off is not a measured treatment dose, and bouncing it back does not turn it into one. I know of no study showing that a passive patch delivers a measurable therapeutic dose of light.
2. GHK-Cu is real. The jump to "stem cell activation" is not
GHK-Cu is a genuine peptide. Dr. Loren Pickart first isolated it in 1973, and it has been studied for decades, mostly in skin and wound research. Dr. Pickart's work is the science LifeWave leans on, but I can find no sign that he is affiliated with the company. Nothing in that research shows that nudging your blood level of GHK-Cu up by a few billionths of a gram per milliliter switches on stem cells throughout your body.
3. No X39 study has measured stem cells
I searched PubMed, the National Library of Medicine's index of medical research. I searched ClinicalTrials.gov, the federal registry of clinical trials. I also read the papers LifeWave sellers post online. Not one X39 study counts stem cells, measures what they are doing, or compares a health result against a fake patch. A product sold as a "stem cell activation patch" has never been shown to activate stem cells. As for the "more than 80 clinical studies" in that seller handout, I could not find them.
What the published evidence actually shows
| Study | Who and how many | What it measured | What it found |
|---|---|---|---|
| Connor et al. Internal Medicine Research – Open Journal, 2021 (not indexed in PubMed) |
58 adults, real or fake patch, one week | One blood peptide (GHK-Cu) | Neither group changed significantly from its own starting level. One chosen time window differed. No health outcomes, no stem cells. |
| Connor et al. pilot, unpublished |
10 adults, no comparison group | Blood peptides | Levels rose. With no comparison group, there is no way to know the patch caused it. |
| Kneller J Innov Card Rhythm Manag, 2024 |
One patient | Wound healing after pacemaker removal | Author reports faster healing. One patient, no comparison. |
| Kneller Cureus, 2025 |
One patient, three different LifeWave patches | A blood collection under the skin | Author reports healing ">500% faster" than expert estimates. One patient, no comparison. |
| Fiddler et al. Int J Exerc Sci, 2011 |
22 college runners, real or fake patch | Endurance (an earlier LifeWave energy patch) | No performance benefit. |
| LifeWave's own trial NCT07706361 |
100 adults planned | Blood peptide levels | Not started. Enrollment opens January 2027. |
Look at that last row. LifeWave was founded more than 20 years ago. The only LifeWave trial registered on ClinicalTrials.gov has not enrolled a single person, and what it plans to measure is a blood peptide. Not pain. Not healing. Not stem cells.
The best study in the table, the 58-person trial, was published in a journal PubMed does not index. Its numbers swing so widely that the spread is bigger than the average. Two of its authors work at the lab that ran the blood tests, and the paper has no funding or conflict-of-interest statement. That is not evidence I would accept for anything I put in a patient.
The sales model is the second risk
X39 is sold through multi-level marketing. Customers are recruited to become "Brand Partners," who earn money by selling patches and recruiting other sellers.
On April 27, 2026, the FTC sued Steven and Gina Merritt, two of LifeWave's highest-ranked sellers. The agency alleged they lured recruits with false earnings promises. In one recruiting video cited by the FTC, Gina Merritt told the room she could not wait to help them reach the top rank "and make $25,000 or more a week." Steven Merritt said the money "keeps coming, even if you don't show up."
The FTC compared those promises with LifeWave's own 2024 income disclosure:
- 79% of active Brand Partners earned no commissions at all in 2024.
- The average active U.S. Brand Partner earned $651 for the year, before expenses.
- At the entry rank, where more than 92% of participants sit, the median was $0.
- At most 0.035% of participants earned what the Merritts described.
The Merritts agreed to a settlement order filed in federal court that bans them from making misleading earnings claims and requires them to tell their downline about the case. LifeWave itself was not a defendant.
Now put the science and the sales model together. You are told a patch activates your stem cells, a claim no study has tested. You are told to keep wearing it for months before you judge it. One seller's site passes along LifeWave guidance of one month for every decade of your age, so five months if you are 50. LifeWave's own page lists X39 at $149.95 a box, or $99.95 a month on subscription. Five months on subscription is about $500. The person telling you this may earn a commission on every sleeve you buy, and may be recruiting you to sell it. That combination is how people get hurt financially by a product they cannot evaluate.
Why the penalty was zero, and why that matters
The FTC's order against the Merritts carries no fine, no refunds and no repayment. In my opinion, that is not enough to protect anyone. An order that says "stop doing it" after years of recruiting does nothing for the people already recruited.
But it is worth knowing why. In 2021, in AMG Capital Management v. FTC, a unanimous Supreme Court ruled that the law the FTC used here, Section 13(b), lets it ask a court to stop a practice but not to make anyone pay money back. Unless Congress changes the law, cases like this one will keep ending in orders with no money attached. If you think that is wrong, as I do, your member of Congress is the person to tell.
The rest of the legal record
Here is everything else I could confirm in court and regulatory records:
- Industry watchdog, 2023, 2025 and 2026. The Direct Selling Self-Regulatory Council, run by BBB National Programs, has opened at least three inquiries into LifeWave marketing. In 2025 it flagged sellers' posts promising "financial freedom" and claiming X39 benefits were "immediate." LifeWave did not try to back up any of the claims. It had the posts removed and suspended one repeat offender for three months. In 2026 the council flagged more earnings claims and posts suggesting LifeWave products could treat conditions such as Alzheimer's.
- FDA. I found no FDA approval, clearance or warning letter for X39. In June 2025 a patient filed a report in the FDA's adverse event database. She wrote that she had been told the patches would shrink her brain tumor, and that a later MRI showed the tumor had grown. These reports are not verified by the FDA, but this one describes the harm I worry about most: a patch used in place of real care.
- Australia, 2009. An Australian advertising complaints panel found that a LifeWave patch website broke the country's therapeutic advertising code. It ordered the ads withdrawn, including a claim that Olympic swimmer Michael Phelps used the patches.
- Ireland, 2015. LifeWave's European arm paid Irish tax authorities €164,000 to settle underpaid corporation tax and VAT.
- Lawsuits. A 2025 class action in Oregon alleges unwanted marketing text messages. A 2025 breach-of-contract lawsuit against LifeWave in Georgia was sent to private arbitration in 2026. Other cases involve patents, trademarks and a 2015 dispute with a rival MLM.
What I did not find: any class action over the patches' health or stem cell claims, any FDA enforcement action, or any FBI or Justice Department case. Several websites describe a "LifeWave class action" over false advertising. I could not find a case number or court record behind any of them, so I am not repeating them here.
How to protect yourself from any "stem cell" product
Ask these five questions before you buy anything that claims to work on stem cells, from anyone, including me:
- Show me the trial. Was it compared against a placebo, and did it measure the result I care about, like pain, function or healing? A blood marker is not a result.
- Is it registered? Look it up on ClinicalTrials.gov. Real trials are registered before they start.
- Did it measure stem cells? If the product is sold on stem cells, someone should have counted them.
- Does the person recommending it get paid if I buy? That does not make them wrong, but you should know.
- Am I putting off care I need? If you have cancer, a serious injury or a diagnosis your doctor is treating, a patch is not a substitute.
If someone is recruiting you to sell, ask for the company's income disclosure statement, then read the median, not the top earners.
The honest limits
"No evidence it works" is not the same as "proven not to work." Nobody has run a good trial of X39 on a health outcome, in either direction. If LifeWave's planned trial is well run and published, I will read it.
The FTC case is about income claims, not health claims. No court or regulator has ruled on whether X39 does what sellers say. Sellers' statements are theirs, not LifeWave's official materials. In the 2025 inquiry, the company did act to remove sellers' unsupported posts.
What I can tell you is this: a product sold on stem cell activation has never been shown to activate stem cells, and it is sold through a business model where, by the company's own numbers, most participants earn nothing.
Common questions
- Does the LifeWave X39 patch really activate stem cells?
- No published study has shown that it does. The only placebo-controlled X39 study I could find followed 58 adults for one week and measured a single copper peptide in the blood. It never measured stem cells or any health outcome, and neither group changed significantly from its starting level. LifeWave's own registered trial, set to begin in January 2027, also measures only blood peptide levels.
- Is there a LifeWave class action lawsuit?
- Not over the patches' health claims, as of November 2026. The only class action I found is Weingrad v. LifeWave, filed in federal court in Oregon in May 2025, and it alleges unwanted marketing text messages. Websites describing a LifeWave false-advertising class action cite no case number or court record that I could verify.
- What did the FTC do about LifeWave?
- In April 2026 the FTC sued Steven and Gina Merritt, two of LifeWave's top-ranked sellers, alleging false earnings claims such as making $25,000 or more a week. LifeWave's own 2024 disclosure showed 79 percent of active participants earned no commissions. The Merritts agreed to a settlement order filed in federal court banning such claims. The order carries no fine, and LifeWave itself was not sued.
More questions
Are LifeWave patches FDA approved?
I found no FDA approval or clearance for X39, and McGill University's Office for Science and Society could not find LifeWave's patches in the FDA's device registration and listing database. LifeWave's own X39 page carries the standard notice that its statements have not been evaluated by the FDA and that the product is not meant to diagnose or treat disease. Read that notice next to the "stem cell activation" claim.
Can the patches hurt me?
No published safety study exists, so nobody can tell you. The clearer risks are financial and delay of care: paying for months of patches on an untested claim, or using them instead of treatment you need. If you are using patches for a serious condition, tell the doctor treating it.
References
Federal Trade Commission. FTC takes action against high-level MLM participants who deceived workers about the amount of money they can earn. April 27, 2026. FTC press release · Complaint · Order
AMG Capital Management, LLC v. FTC, 593 U.S. 67 (2021). Opinion
LifeWave. Renowned Johns Hopkins doctor, Paul J. Christo, explores LifeWave phototherapy technology. Press release. April 11, 2016. PR Newswire
LifeWave. LifeWave notches prestigious Inc. 5000 distinction for the 4th time. Press release. August 31, 2021. PR Newswire
LifeWave. X39 product page and Cellular Performance System page. Screenshots captured November 16, 2026. lifewave.com
Connor CA, Connor MH, Yue D, Eickhoff J, Wagner S, Chang A. Double-blind testing of the LifeWave X39 patch to determine GHK-Cu production levels. Intern Med Res Open J. 2021;6(1):1–3. Full text
Kneller J. Phototherapy to facilitate wound healing following pacemaker infection: a promising tool to improve outcomes. J Innov Card Rhythm Manag. 2024;15(12):6122–6125. PubMed · doi:10.19102/icrm.2024.15124
Kneller JR. Accelerated resolution of pacemaker pocket hematoma with adjunctive phototherapy: a case report. Cureus. 2025;17(6):e85378. PubMed · doi:10.7759/cureus.85378
Fiddler RE, Smith DB, Jacobson BH, et al. The effect of energy patches on substrate utilization in collegiate cross-country runners. Int J Exerc Sci. 2011;4(2):113–121. PubMed · doi:10.70252/OZWD7744
LifeWave, Inc. A two-part study investigating the effect of the X39 patch on circulating blood levels of GHK and GHK-Cu in a healthy adult population. ClinicalTrials.gov NCT07706361. ClinicalTrials.gov
Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PubMed · Full text
BBB National Programs, Direct Selling Self-Regulatory Council. Case #199-2025: LifeWave, Inc. March 3, 2025. Decision · Case #254-2026: LifeWave, Inc. Decision
U.S. Food and Drug Administration. MAUDE adverse event report MW5171944. Received June 25, 2025. FDA MAUDE
Knoepfler P. LifeWave X39 stem cell patch story has holes. The Niche. February 2023. Article
McGill Office for Science and Society. Patchy science on LifeWave's mysterious patches. Article
Paul M. Lifewave's miraculous patches don't keep the dreaded taxman away. Irish Times. December 11, 2015. Article
Further reading: published research
Don Buford, MD is a board certified orthopedic surgeon. That matters here because the same physician who can offer you an orthobiologic injection can also tell you honestly when an injection is not the right answer and an operation is. A clinic that cannot perform the surgery has no way to make that comparison.
